Model N State Price Transparency Management

In recent years, prescription drug pricing has received increased scrutiny, extensive media coverage, and the attention of US lawmakers. The combination of high-profile wholesale acquisition cost (WAC) increases and the inability of the federal government to address concerns about this common practice has led many US states to propose and pass legislation on price transparency. Product Highlights Include:

Governance: Track and record all activity in a single application for simplified evidence collection in the event of an audit

Report templates and on-demand generation:

• Address unique reporting needs, including data fields, rules, and formats
• Autogenerate reports based on each state’s unique triggering events to ensure state-specific timelines are always met

Legislation repository: Configure and continuously update legislation rules based on state specific regulations

What-if analysis: Analyze potential downstream impacts of future pricing or product events, such as price increases or new product launches

State Price Transparency Management delivers the right balance of automation, flexibility, and diligence to ensure the reporting is accurate and punctual.